138
Participants
Start Date
June 30, 2007
Primary Completion Date
August 31, 2009
Study Completion Date
August 31, 2009
Bupivacaine HCl
150 mg Bupivacaine HCl
SKY0402
600 mg SKY0402 (study drug)
Regional Hospital Kladno, Kladno
St. Luke's Roosevelt Hospital, New York
West Alabama Research, Inc., Birmingham
The Ohio State University Medical Center, Columbus
Urazova Nemocnice Brno, Brno
The Hospital Trebic, Třebíč
Texas Tech University Health Science Center, Lubbock
Accurate Clinical Trials, Inc., Laguna Hills
California Clinical Research, Inc., Davis
Lead Sponsor
Pacira Pharmaceuticals, Inc
INDUSTRY